Journal
BJU INTERNATIONAL
Volume 102, Issue 7, Pages 774-779Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1464-410X.2008.07769.x
Keywords
adherence; overactive bladder; pharmacotherapy
Categories
Ask authors/readers for more resources
Drug therapy for overactive bladder (DAB) is associated with improvements in symptoms and quality of life, but the short- and long-term adherence and persistence is suboptimal. In this review we outline methods of measuring, and factors affecting, adherence to pharmacatherapy in patients with CAB. Clinical practice suggests that adherence rates reported in clinical trials art much greater than in real practice. Factors affecting adherence include psychological and social variables that might alter patients' perception of the benefits of taking medication, and the effect of comorbidity and polypharmacy. Whilst there is some evidence that lack of efficacy and side-effects are contributory, these additional factors are also important.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available